|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs显示文摘 | John L. Rinn Michael Kertesz Jordon K. Wang Sharon L. Squazzo Xiao Xu Samantha A. Brugmann L. Henry Goodnough Jill A. Helms Peggy J. Farnham Eran Segal Howard Y. Chang | 2007 | Cell2007，，7： | 6 |
| 2 | Spontaneous hepatic rupture: 13-year experience of a single center显示文摘 | Daniel Maoz Eran Sharon Yakov Chen Franklin Grief | 2010 | European Journal of Gastroenterology & Hepatology2010，，8： | 1 |
| 3 | An efficient message-passing schedule for LDPC decoding 显示文摘 | SHARON ERAN | 2004 | IEEE Commun Left2004，，4： | 1 |
| 4 | Buckling cascades in free sheets显示文摘 | Benoit Roman Eran Sharon | 2002 | Nature2002，419，： | 1 |
| 5 | Geometrically driven wrinkling observed in free plastic sheets and leaves显示文摘 | Eran Sharon Benolt Roman Harry L Swinney | 2007 | American Physical Society2007，75，04： | 1 |
| 6 | Geometry and mechanics in the opening of chiral seed pods显示文摘 | Shahaf Armon Eft Efrati Raz Kupferman Eran Sharon | | 0，，： | 1 |
| 7 | Geometry and mechanics in the opening of chiral seed pods Supplementary online material显示文摘 | Shahaf Armon Eft Efrati Eran Sharon Raz Kupferman | | 0，，： | 1 |
| 8 | Whole-genome sequencing reveals principles of brain retrotransposition in neurodevelopmental disorders显示文摘神经祖先房间经历体的 retrotransposition 事件,主要包含 L1 元素,它能是潜在地有害的。这里,我们分析 20 件大脑样品和 80 件非大脑样品的整个染色体,并且描绘了许多 neurodevelopmental 混乱包括 Rett 症候群,有块茎的硬化,混乱毛细管扩张和孤独性影响的病人的 retrotransposition 风景。我们比在病理学对正常的大脑在非大脑样品并且甚至更高观察了的报导在大脑纸巾的 retrotranspositions 的数字高。体的大脑 retrotransposons 的多数把重复元素集成到先存在,优先地, A/T 富有的 L1 定序,导致嵌套的插入。我们的调查结果文件在 L1 大脑插入事件的多数的编码 endonuclease 独立人士机制的指纹。插入是非古典的因为他们在两结束被截断,当主人元素,和他们的目标序列与大多数另外的 retrotranspositions 的古典 endonuclease 主题相对照与一个 CCATT 主题被充实,在一样的取向集成。我们显示出元素优先地集成到与神经功能和疾病联系的基因的那 L1Hs。当保卫免于有害事件时,我们为新奇插入作为闪电杆建议那先存在的 retrotransposons 行为,它可以给基因表示的好调整。压倒性地不受管束的 retrotransposition 可以突破这保护措施机制并且在 neurodevelopmental 混乱增加有害 mutagenesis 的风险。 | Jasmine Jacob-Hirsch Eran Eyal Binyamin A Knisbacher Jonathan Roth Karen Cesarkas Chen Dor Sarit Farage-Barhom Vered Kunik Amos J Simon Moran Gal Michal Yalon Sharon Moshitch-Moshkovitz Rick Tearle Shlomi Constantini Erez Y Levanon Ninette Amariglio Gideon Rechavi | 2018 | Cell Research2018，28，2： | 1 |
| 9 | An efficient message-passing schedule for LDPC decoding显示文摘 | Eran Sharon | 2004 | IEEE Commun Lett2004，4，： | 1 |
| 10 | Five years of fecal microbiota transplantation-an update of the Israeli experience显示文摘AIM To evaluate and describe the efficacy of fecal microbiota transplantation(FMT) for Clostridium difficile infection(CDI) in a national Israeli cohort.METHODS All patients who received FMT for recurrent(recurrence within 8 wk of the previous treatment) or refractory CDI from 2013 through 2017 in all the five medical centers in Israel currently performing FMT were included. Stool donors were screened according to the Israeli Ministry of Health guidelines. Clinical and laboratory data of patients were collected from patients' medical files, and they included indications for FMT, risk factors for CDI and disease severity. Primary outcome was FMT success(at least 2 mo free of CDI-related diarrhea post-FMT). Secondary outcomes included initial response to FMT(cessation of diarrhea within 7 d) and recurrence at 6 mo.RESULTS There were 111 FMTs for CDI, with a median age of 70 years [interquartile range(IQR): 53-82], and 42%(47) males. Fifty patients(45%) were treated via the lower gastrointestinal(LGI, represented only by colonoscopy) route, 37(33%) via capsules, and 24(22%) via the upper gastrointestinal(UGI) route. The overall success rate was 87.4%(97 patients), with no significant difference between routes of administration(P = 0.338). In the univariant analysis, FMT success correlated with milder disease(P = 0.01), ambulatory setting(P < 0.05) and lower Charlson comorbidity score(P < 0.05). In the multivariant analysis, only severe CDI [odd ratio(OR) = 0.14, P < 0.05] and inpatient FMT(OR = 0.19, P < 0.05) were each independently inversely related to FMT success. There were 35(32%) patients younger than 60 years of age, and 14(40%) of them had a background of inflammatory bowel disease.CONCLUSION FMT is a safe and effective treatment for CDI, with capsules emerging as a successful and well-tolerated route. Severe CDI is less likely to respond to FMT. | Sharon A Greenberg Ilan Youngster Nathaniel A Cohen Dan M Livovsky Jacob Strahilevitz Eran Israeli Ehud Melzer Kalman Paz Naomi Fliss-Isakov Nitsan Maharshak | 2018 | World Journal of Gastroenterology2018，24，47： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员